Skip to main content
. 2021 Apr 22;11:645745. doi: 10.3389/fonc.2021.645745

Figure 4.

Figure 4

Proposed mechanisms of p53 tumor suppressor immune gene therapy mediated by increased interferon signaling with decreased expression of immunosuppressive oncogenes beta-catenin and TGF-beta leading to increased immune inflammation signatures and CD8 positive T cells.